Skip to main content
Mishaela Rubin, MD, Endocrinology, New York, NY

MishaelaRuthRubinMD

Endocrinology New York, NY

Diabetes, Lipid Metabolism

Assistant Professor, Medicine, Columbia University College of Phys & Surg

Overview of Dr. Rubin

Dr. Mishaela Rubin is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 22 years. Dr. Rubin accepts several types of health insurance, listed below. She is one of 142 doctors at New York-Presbyterian Hospital and one of 58 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Endocrinology. She has more than 100 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 1999 - 2002
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1995 - 1998
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1995

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1996 - 2026
  • NJ State Medical License
    NJ State Medical License 1998 - 2025

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Comparative Effect of rhPTH(1‐84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal Osteoporosis  
    Mishaela R Rubin, Donald J McMahon, John P Bilezikian, Natalie E Cusano, Journal of Bone and Mineral Research

Lectures

  • The Role of Sclerostin in the Regulation of Bone Mass and Strength 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • When Parathyroid Glands Go Rogue 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Hypoparathyroidism: Working Toward Effective Treatment 
    95th Annual Meeting & Expo, San Francisco, California, USA

Press Mentions

  • The Hypoparathyroidism Association Announces Patient Enrollment in First Prospective Hypoparathyroidism Natural History Study
    The Hypoparathyroidism Association Announces Patient Enrollment in First Prospective Hypoparathyroidism Natural History StudyMay 23rd, 2023
  • TransCon PTH Nears U.S. Approval for Hypoparathyroidism?
    TransCon PTH Nears U.S. Approval for Hypoparathyroidism?May 17th, 2023
  • Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021
    Ascendis Pharma A/S Presents 6-Month Open-Label Extension Data from Phase 2 PaTH Forward Trial of TransCon PTH in Adult Hypoparathyroidism at ENDO 2021March 23rd, 2021
  • Join now to see all

Grant Support

  • The Skeletal Effects Of Reducing Inflammation In Type 2 Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases2010
  • Circulating Osteoblast Lineage Cells In HypoparathyroidismNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2008
  • Bone Quality In Hypoparathyroidism: Effects Of PTHNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008

Insurance Accepted

  • BCBS Blue Card PPO
    BCBS Texas BlueChoice
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment